KR20210090731A - 피부 항노화 처리 - Google Patents

피부 항노화 처리 Download PDF

Info

Publication number
KR20210090731A
KR20210090731A KR1020217021742A KR20217021742A KR20210090731A KR 20210090731 A KR20210090731 A KR 20210090731A KR 1020217021742 A KR1020217021742 A KR 1020217021742A KR 20217021742 A KR20217021742 A KR 20217021742A KR 20210090731 A KR20210090731 A KR 20210090731A
Authority
KR
South Korea
Prior art keywords
group
composition
unsubstituted
substituted
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217021742A
Other languages
English (en)
Korean (ko)
Inventor
유한 세브리안 푸체
누리아 알미나나 도메네크
라퀠 델가도 곤잘레스
라?? 델가도 곤잘레스
Original Assignee
리포텍 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리포텍 에스.에이. filed Critical 리포텍 에스.에이.
Publication of KR20210090731A publication Critical patent/KR20210090731A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020217021742A 2010-06-09 2011-06-08 피부 항노화 처리 Ceased KR20210090731A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/797,222 US20110305735A1 (en) 2010-06-09 2010-06-09 Skin antiaging treatment
US12/797,222 2010-06-09
KR1020197035199A KR20190135555A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
PCT/EP2011/002799 WO2011154126A2 (en) 2010-06-09 2011-06-08 Skin antiaging treatment

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197035199A Division KR20190135555A (ko) 2010-06-09 2011-06-08 피부 항노화 처리

Publications (1)

Publication Number Publication Date
KR20210090731A true KR20210090731A (ko) 2021-07-20

Family

ID=44627143

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020217021742A Ceased KR20210090731A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020187020082A Ceased KR20180083958A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020197035199A Ceased KR20190135555A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020137000438A Ceased KR20130135819A (ko) 2010-06-09 2011-06-08 피부 항노화 처리

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020187020082A Ceased KR20180083958A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020197035199A Ceased KR20190135555A (ko) 2010-06-09 2011-06-08 피부 항노화 처리
KR1020137000438A Ceased KR20130135819A (ko) 2010-06-09 2011-06-08 피부 항노화 처리

Country Status (13)

Country Link
US (1) US20110305735A1 (enExample)
EP (1) EP2579952B1 (enExample)
JP (2) JP6306885B2 (enExample)
KR (4) KR20210090731A (enExample)
CN (1) CN103096980B (enExample)
AU (1) AU2011264125B2 (enExample)
BR (1) BR112012031117B1 (enExample)
CA (1) CA2801961C (enExample)
CO (1) CO6640331A2 (enExample)
ES (1) ES2654342T3 (enExample)
MX (1) MX342853B (enExample)
WO (1) WO2011154126A2 (enExample)
ZA (1) ZA201209484B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117297997A (zh) * 2023-11-28 2023-12-29 杭州湃肽生化科技有限公司 一种高效紧肤多肽组合物及其产品应用

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP2482838A4 (en) * 2009-09-30 2013-04-10 Toxcure Inc USE OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF SUBSTANCE DEPENDENCE
US9233062B2 (en) 2011-05-10 2016-01-12 Mary Kay Inc. Cosmetic compositions
JP5889220B2 (ja) * 2012-03-30 2016-03-22 富士フイルム株式会社 水性分散組成物
EP2649984A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
US8758783B1 (en) 2012-12-20 2014-06-24 L'oreal Water-in-oil emulsion comprising pigments in the water phase
RU2524663C1 (ru) * 2013-04-26 2014-07-27 Общество с ограниченной ответственностью "ДЖИ-Групп" Комплексное косметическое средство
CN103505377B (zh) * 2013-09-11 2015-06-03 深圳市维琪医药研发有限公司 一种具皮肤活性的多肽组合物
CA2928526A1 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN103641888B (zh) * 2013-12-03 2015-08-12 广州健坤生物科技有限公司 一种多功能新型小肽、包含该肽的组合物及其应用
CN103637925B (zh) * 2013-12-03 2015-09-30 广州健坤生物科技有限公司 γ-氨基丁酸(GABA)和一种小肽在化妆品中的联合应用
CN104000744A (zh) * 2014-06-12 2014-08-27 金玲 一种改善肌肤新陈代谢并能延缓衰老的美容用液及其生产方法
CN107205889B (zh) * 2014-09-02 2021-05-11 美国白银有限责任公司 肉毒毒素和胶体银颗粒
CN107427474A (zh) 2015-04-13 2017-12-01 株式会社Lg生活健康 含有调节神经递质释放的成分的可溶性微针
WO2016167545A1 (ko) * 2015-04-13 2016-10-20 주식회사 엘지생활건강 신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들
KR102203633B1 (ko) * 2015-04-14 2021-01-15 주식회사 엘지생활건강 칼슘채널 차단제 전달용 용해성 미세바늘
KR101843065B1 (ko) * 2016-01-06 2018-03-28 바이오스펙트럼 주식회사 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US11478409B2 (en) * 2016-05-24 2022-10-25 Natura Cosmeticos S.A. Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment
KR101895906B1 (ko) * 2016-07-07 2018-10-04 주식회사 한국화장품제조 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
US20180133131A1 (en) * 2016-11-14 2018-05-17 Ariix Skin rejuvenating compositions
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
JP7191386B2 (ja) * 2017-02-24 2022-12-19 リポトゥルー，エセ．エレ． 化粧料に使用するためのペプチドおよび組成物
US10258556B2 (en) * 2017-06-19 2019-04-16 Yu-Chun Liu Anti-aging peptide, its composition and method of using the same
KR102311724B1 (ko) * 2017-09-15 2021-10-13 (주)아모레퍼시픽 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
CN107693391A (zh) * 2017-11-21 2018-02-16 上海合轩品牌管理有限公司 一种抗皱眼霜及其制备方法
KR102041561B1 (ko) * 2018-02-23 2019-11-06 주식회사 메디쿼터스 미세먼지 차단용 피부화장료 조성물 및 겔 조성물
US11191819B2 (en) * 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics
CN109293737B (zh) * 2018-09-27 2020-10-27 华南理工大学 一种抗皮肤衰老的四肽及其用途
KR102139472B1 (ko) * 2018-10-31 2020-07-30 에이앤펩주식회사 기능성 펩타이드와 발효물을 포함하는 피부노화 개선용 조성물
EP4393504A2 (en) * 2018-12-26 2024-07-03 Skinmed Co., Ltd. Acetylcholine receptor inhibitory peptides and uses thereof
GB202004804D0 (en) * 2020-04-01 2020-05-13 Neuro Bio Ltd Skin
CN111904881B (zh) * 2020-08-11 2023-05-23 上海科颜生物科技有限公司 一种抗衰紧致组合物及其制备方法和应用
CN113307851B (zh) * 2021-06-11 2022-04-29 珠海医美企业管理有限公司 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用
CN113577364A (zh) * 2021-08-13 2021-11-02 常州谙美生物科技有限公司 一种用于晒后修复的医用敷料
CN115400043B (zh) * 2022-08-04 2023-10-31 广州环亚化妆品科技股份有限公司 一种抗皱组合物及其制备方法和在化妆品中的应用
CN116003518B (zh) * 2023-01-10 2023-09-29 深圳市维琪科技股份有限公司 经设计的肽及其组合物和用途
CN116747148B (zh) * 2023-07-24 2024-10-01 山东福瑞达生物股份有限公司 一种适用于敏感肌的抗衰化妆品组合物
KR102834921B1 (ko) * 2023-08-14 2025-07-18 허가영 조직수복 및 피부탄력 개선용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE228834T1 (de) 1994-09-30 2002-12-15 Oreal Verwendung von einem agonisten eines mit einem chloridkanal assozierten rezeptors zur behandlung von hautfalten
AU2334897A (en) * 1996-03-18 1997-10-10 Regents Of The University Of California, The Peptide inhibitors of neurotransmitter secretion by neuronal cells
FR2746641B1 (fr) 1996-03-27 1998-06-05 Oreal Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
ES2160485B1 (es) 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
FR2798590B1 (fr) 1999-09-21 2001-11-30 Oreal Utilisation de l'alverine pour diminuer les rides
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
FR2809005B1 (fr) 2000-05-18 2002-12-27 Oreal Utilisation du manganese dans le traitement des rides
FR2846885B1 (fr) 2002-11-13 2004-12-24 Oreal Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules
ES2259928B1 (es) 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117297997A (zh) * 2023-11-28 2023-12-29 杭州湃肽生化科技有限公司 一种高效紧肤多肽组合物及其产品应用

Also Published As

Publication number Publication date
BR112012031117A2 (pt) 2016-08-23
EP2579952B1 (en) 2017-11-08
EP2579952A2 (en) 2013-04-17
CN103096980B (zh) 2018-02-09
BR112012031117B1 (pt) 2018-01-16
CA2801961A1 (en) 2011-12-15
JP2018058842A (ja) 2018-04-12
ES2654342T3 (es) 2018-02-13
WO2011154126A2 (en) 2011-12-15
US20110305735A1 (en) 2011-12-15
AU2011264125A1 (en) 2012-12-20
JP2013533226A (ja) 2013-08-22
JP6306885B2 (ja) 2018-04-04
WO2011154126A3 (en) 2012-07-26
KR20180083958A (ko) 2018-07-23
CN103096980A (zh) 2013-05-08
MX342853B (es) 2016-10-14
ZA201209484B (en) 2014-02-26
KR20190135555A (ko) 2019-12-06
KR20130135819A (ko) 2013-12-11
CO6640331A2 (es) 2013-03-22
MX2012014389A (es) 2013-01-29
AU2011264125B2 (en) 2015-03-19
CA2801961C (en) 2018-11-20

Similar Documents

Publication Publication Date Title
JP6306885B2 (ja) 皮膚の抗老化治療
CN104968360B (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
JP5818356B2 (ja) 皮膚、粘膜、頭皮、及び／若しくは毛髪の処置及び／若しくはケアに有用なペプチド並びに／又は化粧品組成物若しくは医薬組成物におけるその使用
KR101757946B1 (ko) 근 수축을 억제하는 화합물
CA2751436C (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
US11896704B2 (en) Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
KR101988676B1 (ko) Pgc-1알파 조절 펩티드
JP7686563B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
KR20120105450A (ko) 피부, 점막 및/또는 모발의 치료 및/또는 관리에 사용되는 펩티드 및 화장품학적 또는 약제학적 조성물에 있어서의 이의 용도
US20130078295A1 (en) Skin antiaging treatment
JP7526159B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
JP2025527593A (ja) 皮膚、毛髪、爪及び／又は粘膜の処置及び／又はケアに有用な化合物

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20210712

Application number text: 1020197035199

Filing date: 20191128

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210810

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210820

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220404

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210820

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20220404

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20220321

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20220713

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20220630

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20220404

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20220321

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20210820

X601 Decision of rejection after re-examination
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20221212

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20220713

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Patent event date: 20220404

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2022101002270

Request date: 20221212

J301 Trial decision

Free format text: TRIAL NUMBER: 2022101002270; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20221212

Effective date: 20231116

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20231116

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20221212

Decision date: 20231116

Appeal identifier: 2022101002270